Lipid‐based nanoparticles for contrast‐enhanced MRI and molecular imaging
暂无分享,去创建一个
Klaas Nicolay | Gustav J Strijkers | Willem J M Mulder | Arjan W Griffioen | K. Nicolay | A. Griffioen | G. Strijkers | W. Mulder | Geralda A. F. van Tilborg | Geralda A F van Tilborg
[1] Rika Takikawa,et al. [In-vivo visualization of gene expression using magnetic resonance imaging]. , 2007, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.
[2] H. Weinmann,et al. Gadofluorine 8: initial experience with a new contrast medium for interstitial MR lymphography , 1999, Magnetic Resonance Materials in Physics, Biology and Medicine.
[3] Klaas Nicolay,et al. Quantum dots with a paramagnetic coating as a bimodal molecular imaging probe. , 2006, Nano letters.
[4] Klaas Nicolay,et al. MR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticle , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[5] K. Nicolay,et al. Relaxivity of liposomal paramagnetic MRI contrast agents , 2005, Magnetic Resonance Materials in Physics, Biology and Medicine.
[6] Enzo Terreno,et al. Highly sensitive MRI chemical exchange saturation transfer agents using liposomes. , 2005, Angewandte Chemie.
[7] Eric T Ahrens,et al. In vivo imaging platform for tracking immunotherapeutic cells , 2005, Nature Biotechnology.
[8] Valérie Cabuil,et al. Generation of superparamagnetic liposomes revealed as highly efficient MRI contrast agents for in vivo imaging. , 2005, Journal of the American Chemical Society.
[9] Marcelino Bernardo,et al. Gadolinium-rhodamine nanoparticles for cell labeling and tracking via magnetic resonance and optical imaging. , 2005, Bioconjugate chemistry.
[10] J. Baselga,et al. Critical update and emerging trends in epidermal growth factor receptor targeting in cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] Walter H Backes,et al. Dynamic contrast-enhanced MR imaging kinetic parameters and molecular weight of dendritic contrast agents in tumor angiogenesis in mice. , 2005, Radiology.
[12] C. Wessig,et al. Assessment of nerve degeneration by gadofluorine M–enhanced magnetic resonance imaging , 2005, Annals of neurology.
[13] M. Ferrari. Cancer nanotechnology: opportunities and challenges , 2005, Nature Reviews Cancer.
[14] A. C. Hunter,et al. Nanomedicine: current status and future prospects , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[15] Ralph Weissleder,et al. Detection of Vascular Adhesion Molecule-1 Expression Using a Novel Multimodal Nanoparticle , 2005, Circulation research.
[16] V. Torchilin. Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.
[17] S. Gambhir,et al. Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics , 2005, Science.
[18] V. Torchilin. Fluorescence microscopy to follow the targeting of liposomes and micelles to cells and their intracellular fate. , 2005, Advanced drug delivery reviews.
[19] Shelton D Caruthers,et al. Molecular imaging of human thrombus with computed tomography. , 2005, Academic radiology.
[20] V. Pierre,et al. Next generation, high relaxivity gadolinium MRI agents. , 2005, Bioconjugate chemistry.
[21] Daowen Wang,et al. [Correlation of thrombospondin-1 G1678A polymorphism to stroke: a study in Chinese population]. , 2004, Zhonghua yi xue za zhi.
[22] Patrick J. Gaffney,et al. Quantitative “magnetic resonance immunohistochemistry” with ligand‐targeted 19F nanoparticles , 2004 .
[23] C. Benz,et al. Future directions of liposome- and immunoliposome-based cancer therapeutics. , 2004, Seminars in oncology.
[24] Atle Bjørnerud,et al. Experimental application of thermosensitive paramagnetic liposomes for monitoring magnetic resonance imaging guided thermal ablation , 2004, Magnetic resonance in medicine.
[25] François Mach,et al. Inflammation and Atherosclerosis , 2004, Herz.
[26] Zahi A Fayad,et al. Recombinant HDL-like nanoparticles: a specific contrast agent for MRI of atherosclerotic plaques. , 2004, Journal of the American Chemical Society.
[27] R. Zhou,et al. MR and fluorescent imaging of low-density lipoprotein receptors. , 2004, Academic radiology.
[28] Jeff W M Bulte,et al. Iron oxide MR contrast agents for molecular and cellular imaging , 2004, NMR in biomedicine.
[29] Shelton D Caruthers,et al. Magnetic resonance molecular imaging with nanoparticles , 2004, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[30] Zahi A. Fayad,et al. Molecular, cellular and functional imaging of atherothrombosis , 2004, Nature Reviews Drug Discovery.
[31] B. Marincek,et al. Detection of synovial macrophages in an experimental rabbit model of antigen-induced arthritis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging. , 2004, Radiology.
[32] V. Torchilin,et al. Targeted polymeric micelles for delivery of poorly soluble drugs , 2004, Cellular and Molecular Life Sciences CMLS.
[33] Stefano Colagrande,et al. Persistent contrast enhancement by sterically stabilized paramagnetic liposomes in murine melanoma , 2004, Magnetic resonance in medicine.
[34] Ralph Weissleder,et al. Magneto/optical annexin V, a multimodal protein. , 2004, Bioconjugate chemistry.
[35] Kevin M Brindle,et al. Detection of apoptosis using the C2A domain of synaptotagmin I. , 2004, Bioconjugate chemistry.
[36] Xiaoping P. Hu,et al. Functionalization and peptide-based delivery of magnetic nanoparticles as an intracellular MRI contrast agent , 2004, JBIC Journal of Biological Inorganic Chemistry.
[37] K. Nicolay,et al. A liposomal system for contrast-enhanced magnetic resonance imaging of molecular targets. , 2004, Bioconjugate chemistry.
[38] V. Fuster,et al. Lipid-Rich Atherosclerotic Plaques Detected by Gadofluorine-Enhanced In Vivo Magnetic Resonance Imaging , 2004, Circulation.
[39] H. Weinmann,et al. Early MR lymphography with gadofluorine M in rabbits. , 2004, Radiology.
[40] M. Dewhirst,et al. In vivo monitoring of tissue pharmacokinetics of liposome/drug using MRI: Illustration of targeted delivery , 2004, Magnetic resonance in medicine.
[41] Vladimir P Torchilin,et al. Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs. , 2004, Advanced drug delivery reviews.
[42] J. Heverhagen,et al. Encapsulation of gadobutrol in AVE-based liposomal carriers for MR detectability. , 2004, Magnetic resonance imaging.
[43] M. Berger,et al. Extensive Distribution of Liposomes in Rodent Brains and Brain Tumors Following Convection-Enhanced Delivery , 2004, Journal of Neuro-Oncology.
[44] Luigi Biancone,et al. Improved route for the visualization of stem cells labeled with a Gd‐/Eu‐Chelate as dual (MRI and fluorescence) agent , 2004, Magnetic resonance in medicine.
[45] R. Kontermann,et al. Novel RGD lipopeptides for the targeting of liposomes to integrin-expressing endothelial and melanoma cells. , 2004, Protein engineering, design & selection : PEDS.
[46] A. Bjørnerud,et al. Novel pH‐sensitive paramagnetic liposomes with improved MR properties , 2004, Magnetic resonance in medicine.
[47] M. Berger,et al. Distribution of Liposomes into Brain and Rat Brain Tumor Models by Convection-Enhanced Delivery Monitored with Magnetic Resonance Imaging , 2004, Cancer Research.
[48] S. Caruthers,et al. 1054-155 Antiangiogenic therapy of early atherosclerosis with paramagnetic ανβ3-integrin-targeted fumagillin nanoparticles , 2004 .
[49] D Leszczynska,et al. Principles of magnetodynamic chemotherapy. , 2004, Medical hypotheses.
[50] Shelton D Caruthers,et al. Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI , 2004, Magnetic resonance in medicine.
[51] G. D’Errico,et al. Physicochemical properties of mixed micellar aggregates containing CCK peptides and Gd complexes designed as tumor specific contrast agents in MRI. , 2004, Journal of the American Chemical Society.
[52] Ralph Weissleder,et al. Peroxidase Substrate Nanosensors for MR Imaging , 2004 .
[53] A. Griffioen,et al. MR imaging of avb3-expression in tumor bearing mice using RGD-conjugated paramagnetic and fluorescent liposomes , 2004 .
[54] R. Rein,et al. Conformational requirements of suramin to target angiogenic growth factors , 2004, Angiogenesis.
[55] M. Ferrari,et al. Recommendations of the National Heart, Lung, and Blood Institute Nanotechnology Working Group. , 2003, Circulation.
[56] J. O’Shaughnessy. Pegylated liposomal doxorubicin in the treatment of breast cancer. , 2003, Clinical breast cancer.
[57] K. Edwards,et al. Liposomes, disks, and spherical micelles: aggregate structure in mixtures of gel phase phosphatidylcholines and poly(ethylene glycol)-phospholipids. , 2003, Biophysical journal.
[58] Samuel A. Wickline,et al. Molecular Imaging of Angiogenesis in Early-Stage Atherosclerosis With &agr;v&bgr;3-Integrin–Targeted Nanoparticles , 2003 .
[59] M. Neeman,et al. Modulation of the pharmacokinetics of macromolecular contrast material by avidin chase: MRI, optical, and inductively coupled plasma mass spectrometry tracking of triply labeled albumin , 2003, Magnetic resonance in medicine.
[60] R. Weissleder,et al. In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors. , 2003, Cancer research.
[61] L. Helm,et al. 8S paramagnetic centres in molecular assemblies: possible effect of their proximity on the water proton relaxivity , 2003 .
[62] Doris A Taylor,et al. Improved Efficacy of Stem Cell Labeling for Magnetic Resonance Imaging Studies by the Use of Cationic Liposomes , 2003, Cell transplantation.
[63] A. Kassner,et al. Molecular Imaging of Angiogenesis in Nascent Vx-2 Rabbit Tumors Using a Novel ανβ3-targeted Nanoparticle and 1.5 Tesla Magnetic Resonance Imaging , 2003 .
[64] K. Nicolay,et al. Interferon-Beta Prevents Cytokine-Induced Neutrophil Infiltration and Attenuates Blood–Brain Barrier Disruption , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[65] T. Allen,et al. Ligand-targeted liposomal anticancer drugs. , 2003, Progress in lipid research.
[66] J. Debatin,et al. Detection of Atherosclerotic Plaque With Gadofluorine-Enhanced Magnetic Resonance Imaging , 2003, Circulation.
[67] S. Aime,et al. Novel radical‐responsive MRI contrast agent based on paramagnetic liposomes , 2003 .
[68] Sheng-Kwei Song,et al. Improved molecular imaging contrast agent for detection of human thrombus , 2003, Magnetic resonance in medicine.
[69] A. Senoo,et al. Interstitial Magnetic Resonance Lymphography: Comparative Animal Study of Gadofluorine 8 and Gadolinium Diethylenetriamine-Pentaacetic Acid , 2003, Journal of computer assisted tomography.
[70] J. Klaveness,et al. pH-sensitive paramagnetic liposomes for MRI: assessment of stability in blood. , 2003, Magnetic resonance imaging.
[71] Dmitri Artemov,et al. Magnetic resonance molecular imaging of the HER-2/neu receptor. , 2003, Cancer research.
[72] M. E. Kooi,et al. Accumulation of Ultrasmall Superparamagnetic Particles of Iron Oxide in Human Atherosclerotic Plaques Can Be Detected by In Vivo Magnetic Resonance Imaging , 2003, Circulation.
[73] Ergin Atalar,et al. In Vivo Magnetic Resonance Imaging of Mesenchymal Stem Cells in Myocardial Infarction , 2003, Circulation.
[74] Vladimir P. Torchilin,et al. Immunomicelles: Targeted pharmaceutical carriers for poorly soluble drugs , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[75] R. Weissleder,et al. Near-infrared fluorescent imaging of tumor apoptosis. , 2003, Cancer research.
[76] J. Klaveness,et al. Preparation and in vitro evaluation of a novel amphiphilic GdPCTA-[12] derivative; a micellar MRI contrast agent. , 2003, Organic & biomolecular chemistry.
[77] I. Rubinstein,et al. Liposomes in ultrasound and gamma scintigraphic imaging. , 2003, Methods in enzymology.
[78] Shelton D Caruthers,et al. Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles. , 2003, Circulation.
[79] J. Bulte,et al. Magnetoliposomes as contrast agents. , 2003, Methods in enzymology.
[80] Shelton D Caruthers,et al. Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging. , 2003, Cancer research.
[81] D. Scherman,et al. Design, synthesis, and evaluation of gadolinium cationic lipids as tools for biodistribution studies of gene delivery complexes. , 2003, Bioconjugate chemistry.
[82] P. Libby. Inflammation in atherosclerosis , 2002, Nature.
[83] Carl Nathan,et al. Points of control in inflammation , 2002, Nature.
[84] Vincent Noireaux,et al. In Vivo Imaging of Quantum Dots Encapsulated in Phospholipid Micelles , 2002, Science.
[85] Kerry K. Karukstis,et al. Targeted Antiproliferative Drug Delivery to Vascular Smooth Muscle Cells With a Magnetic Resonance Imaging Nanoparticle Contrast Agent: Implications for Rational Therapy of Restenosis , 2002, Circulation.
[86] Mathias Hoehn,et al. Monitoring of implanted stem cell migration in vivo: A highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[87] T. Allen. Ligand-targeted therapeutics in anticancer therapy , 2002, Nature Reviews Cancer.
[88] A. Padhani. Dynamic contrast‐enhanced MRI in clinical oncology: Current status and future directions , 2002, Journal of magnetic resonance imaging : JMRI.
[89] M. Bednarski,et al. Tumor Regression by Targeted Gene Delivery to the Neovasculature , 2002, Science.
[90] John W. Park. Liposome-based drug delivery in breast cancer treatment , 2002, Breast Cancer Research.
[91] Ulrik B Nielsen,et al. Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[92] Jo Klaveness,et al. Liposomes as carriers of amphiphilic gadolinium chelates: the effect of membrane composition on incorporation efficacy and in vitro relaxivity. , 2002, International journal of pharmaceutics.
[93] Vladimir P Torchilin,et al. PEG-based micelles as carriers of contrast agents for different imaging modalities. , 2002, Advanced drug delivery reviews.
[94] R. Schiffelers,et al. Endothelial cells at inflammatory sites as target for therapeutic intervention. , 2002, Endothelium : journal of endothelial cell research.
[95] Kathy Wilkinson,et al. Liposomal doxorubicin. , 2002, Clinical journal of oncology nursing.
[96] Koert N. J. Burger,et al. Nanocapsules: lipid-coated aggregates of cisplatin with high cytotoxicity , 2002, Nature Medicine.
[97] F. Khuri,et al. A phase II study of STEALTH cisplatin (SPI-77) in patients with advanced non-small cell lung cancer. , 2001, Lung cancer.
[98] P. Doevendans,et al. Real-time imaging of apoptotic cell-membrane changes at the single-cell level in the beating murine heart , 2001, Nature Medicine.
[99] Ming Zhao,et al. Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent , 2001, Nature Medicine.
[100] S A Wickline,et al. Novel MRI Contrast Agent for Molecular Imaging of Fibrin: Implications for Detecting Vulnerable Plaques , 2001, Circulation.
[101] A. Bjørnerud,et al. pH-sensitive paramagnetic liposomes as MRI contrast agents: in vitro feasibility studies. , 2001, Magnetic resonance imaging.
[102] A. Bjørnerud,et al. A targeted contrast agent for magnetic resonance imaging of thrombus: Implications of spatial resolution , 2001, Journal of magnetic resonance imaging : JMRI.
[103] Sibylle Ziegler,et al. Noninvasive Imaging of αvβ3 Integrin Expression Using 18F-labeled RGD-containing Glycopeptide and Positron Emission Tomography , 2001 .
[104] Christopher K. Glass,et al. Atherosclerosis The Road Ahead , 2001, Cell.
[105] R. Vile,et al. Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[106] J. Debatin,et al. Magnetic Resonance Imaging of Atherosclerotic Plaque With Ultrasmall Superparamagnetic Particles of Iron Oxide in Hyperlipidemic Rabbits , 2001, Circulation.
[107] D. Shah,et al. Improved drug delivery using microemulsions: rationale, recent progress, and new horizons. , 2001, Critical reviews in therapeutic drug carrier systems.
[108] M. Schwaiger,et al. Noninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomography. , 2001, Cancer research.
[109] A. Bjørnerud,et al. Thermosensitive paramagnetic liposomes for temperature control during MR imaging-guided hyperthermia: in vitro feasibility studies. , 2000, Academic radiology.
[110] P. Carmeliet,et al. Angiogenesis in cancer and other diseases , 2000, Nature.
[111] W. Oyen,et al. Radiolabeled liposomes for scintigraphic imaging. , 2000, Progress in lipid research.
[112] P. Doevendans,et al. Visualisation of cell death in vivo in patients with acute myocardial infarction , 2000, The Lancet.
[113] A. Griffioen,et al. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. , 2000, Pharmacological reviews.
[114] L. Steinman,et al. ICAM-1 expression in autoimmune encephalitis visualized using magnetic resonance imaging , 2000, Journal of Neuroimmunology.
[115] Ralph Weissleder,et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells , 2000, Nature Biotechnology.
[116] Peter Babinec,et al. Site-Specific in vivo Targeting of Magnetoliposomes Using Externally Applied Magnetic Field , 2000, Zeitschrift fur Naturforschung. C, Journal of biosciences.
[117] Aldons J. Lusis,et al. Atherosclerosis : Vascular biology , 2000 .
[118] M. Lawrence,et al. Microemulsion-based media as novel drug delivery systems. , 2000, Advanced drug delivery reviews.
[119] G.,et al. Annexin V for Flow Cytometric Detection of Phosphatidylserine Expression on B Cells Undergoing Apoptosis , 2000 .
[120] D. Papahadjopoulos,et al. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. , 1999, Pharmacological reviews.
[121] Koning,et al. Immunoliposomes for the targeted delivery of antitumor drugs. , 1999, Advanced drug delivery reviews.
[122] C H Lorenz,et al. Contrast‐enhanced coronary MRA , 1999, Journal of magnetic resonance imaging : JMRI.
[123] A de Roos,et al. Blood pool contrast agents for cardiovascular MR imaging , 1999, Journal of magnetic resonance imaging : JMRI.
[124] M. Jones,et al. Polymeric micelles - a new generation of colloidal drug carriers. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[125] R. Lauffer,et al. Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications. , 1999, Chemical reviews.
[126] Yu-Chung N. Cheng,et al. Magnetic Resonance Imaging: Physical Principles and Sequence Design , 1999 .
[127] Oku,et al. Delivery of contrast agents for positron emission tomography imaging by liposomes. , 1999, Advanced drug delivery reviews.
[128] J. Bulte,et al. Short‐ vs. long‐circulating magnetoliposomes as bone marrow‐seeking MR contrast agents , 1999, Journal of magnetic resonance imaging : JMRI.
[129] R. Muller,et al. Paramagnetic liposomes as MRI contrast agents: influence of liposomal physicochemical properties on the in vitro relaxivity. , 1999, Magnetic resonance imaging.
[130] R. Davis,et al. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[131] Enzo Terreno,et al. Lanthanide(III) chelates for NMR biomedical applications , 1998 .
[132] M. Bednarski,et al. Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging. , 1998, Nature medicine.
[133] R. Schiffelers,et al. Human recombinant apolipoprotein E-enriched liposomes can mimic low-density lipoproteins as carriers for the site-specific delivery of antitumor agents. , 1997, Molecular pharmacology.
[134] G. Groenewegen,et al. CD44 is involved in tumor angiogenesis; an activation antigen on human endothelial cells. , 1997, Blood.
[135] W. Chu,et al. In vivo Characterization of Gd(BME‐DTTA), a myocardial MRI contrast agent: tissue distribution of its MRI intensity enhancement, and its effect on heart function , 1997, NMR in biomedicine.
[136] D. Crommelin,et al. Colloidal systems for tumor targeting. , 1997, Hybridoma.
[137] T. Allen,et al. Liposomes , 2012, Drugs.
[138] J. G. Miller,et al. A novel site-targeted ultrasonic contrast agent with broad biomedical application. , 1996, Circulation.
[139] King Li,et al. Paramagnetic polymerized liposomes as new recirculating MR contrast agents , 1995, Journal of magnetic resonance imaging : JMRI.
[140] King C.P. Li,et al. Paramagnetic Polymerized Liposomes: Synthesis, Characterization, and Applications for Magnetic Resonance Imaging , 1995 .
[141] V. Torchilin,et al. Controlled delivery of Gd-containing liposomes to lymph nodes: surface modification may enhance MRI contrast properties. , 1995, Magnetic resonance imaging.
[142] T. Allen. Long-circulating (sterically stabilized) liposomes for targeted drug delivery. , 1994, Trends in pharmacological sciences.
[143] N. Phillips,et al. Immunoliposome targeting to murine CD4+ leucocytes is dependent on immune status. , 1994, Journal of immunology.
[144] E. Unger,et al. Manganese-Based Liposomes Comparative Approaches , 1993, Investigative radiology.
[145] T. Singleton,et al. Stability of HER-2/neu expression over time and at multiple metastatic sites. , 1993, Journal of the National Cancer Institute.
[146] J. Bulte,et al. Selective MR imaging of labeled human peripheral blood mononuclear cells by liposome mediated incorporation of dextran‐magnetite particles , 1993, Magnetic resonance in medicine.
[147] Physics of Amphiphiles : Micelles , Vesicles and Microemulsion , 1993 .
[148] S. H. Koenig,et al. The design of liposomal paramagnetic mr agents: effect of vesicle size upon the relaxivity of surface‐incorporated lipophilic chelates , 1992, Magnetic resonance in medicine.
[149] Stefan Miltenyi,et al. Specific MR imaging of human lymphocytes by monoclonal antibody‐guided dextran‐magnetite particles , 1992, Magnetic resonance in medicine.
[150] E. Unger,et al. Permeability of liposomal membranes to water: Results from the magnetic field dependence of T1 of solvent protons in suspensions of vesicles with entrapped paramagnetic ions , 1992, Magnetic resonance in medicine.
[151] E. Unger,et al. Liposomes as MR contrast agents: Pros and cons , 1991, Magnetic resonance in medicine.
[152] G. Pohost,et al. Fatty‐acyl iminopolycarboxylates: Lipophilic bifunctional contrast agents for NMR imaging , 1991, Magnetic resonance in medicine.
[153] T. Allen,et al. Pharmacokinetics of stealth versus conventional liposomes: effect of dose. , 1991, Biochimica et biophysica acta.
[154] T M Allen,et al. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. , 1991, Biochimica et biophysica acta.
[155] K. Hubner,et al. Gadolinium‐labeled liposomes containing various amphiphilic Gd‐DTPA derivatives: Targeted MRI contrast enhancement agents for the liver , 1991, Magnetic resonance in medicine.
[156] M. Botta,et al. Trends in NMR studies of paramagnetic Gd(III) complexes as potential contrast agents in MRI , 1991 .
[157] L. Huang,et al. Gadolinium-labeled liposomes containing amphiphilic Gd-DTPA derivatives of varying chain length: targeted MRI contrast enhancement agents for the liver. , 1991, Magnetic resonance imaging.
[158] M. de Cuyper,et al. Potentialities of magnetoliposomes in studying symmetric and asymmetric phospholipid transfer processes. , 1990, Biochimica et biophysica acta.
[159] G. V. von Schulthess,et al. A pharmacokinetic and MRI study of unilamellar gadolinium-, manganese-, and iron-DTPA-stearate liposomes as organ-specific contrast agents. , 1990, Investigative radiology.
[160] Kazuo Maruyama,et al. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes , 1990, FEBS letters.
[161] A. Siccardi,et al. Intraperitoneal radio‐localization of tumors pre‐targeted by biotinylated monoclonal antibodies , 1990, International journal of cancer.
[162] S M Wright,et al. Liposome encapsulated MnCl2 as a liver specific contrast agent for magnetic resonance imaging. , 1990, Investigative radiology.
[163] K. Hubner,et al. Gd-labeled liposomes containing amphipathic agents for magnetic resonance imaging. , 1990, Investigative radiology.
[164] R. Gatenby,et al. Hepatic metastases: liposomal Gd-DTPA-enhanced MR imaging. , 1989, Radiology.
[165] P. Cullis,et al. Liposomal Gd-DTPA: preparation and characterization of relaxivity. , 1989, Radiology.
[166] P. Needleman,et al. Gadolinium-DTPA liposomes as a potential MRI contrast agent. Work in progress. , 1988, Investigative radiology.
[167] J. Devoisselle,et al. Entrapment of gadolinium-DTPA in liposomes. Characterization of vesicles by P-31 NMR spectroscopy. , 1988, Investigative radiology.
[168] K. Hubner,et al. Gadolinium‐labeled liposomes containing paramagnetic amphipathic agents: Targeted MRI contrast agents for the liver , 1988, Magnetic resonance in medicine.
[169] S. H. Koenig,et al. Relaxivity and binding of Mn2+ ions in solutions of phosphatidylserine vesicles , 1988, Magnetic resonance in medicine.
[170] M. de Cuyper,et al. Magnetoliposomes , 1988, European Biophysics Journal.
[171] G. Navon,et al. Liposomes containing paramagnetic macromolecules as MRI contrast agents , 1986, Magnetic resonance in medicine.
[172] S M Wright,et al. Liposome delivery of NMR contrast agents for improved tissue imaging , 1986, Magnetic resonance in medicine.
[173] J. Gore,et al. Relaxation enhancement using liposomes carrying paramagnetic species. , 1984, Magnetic resonance imaging.
[174] V A Namiot,et al. Magnetoliposomes: another principle of cell sorting. , 1983, Biochimica et biophysica acta.
[175] I. M. Neiman,et al. [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.
[176] A. Bangham,et al. Diffusion of univalent ions across the lamellae of swollen phospholipids. , 1965, Journal of molecular biology.